Munich, 81377
Germany
Ludwig Maximilian University of Munich (LMU) - Department of Radiation Oncology
network meta-analysis, chemotherapy, hyperthermia, surgery, overall survival
Prospective Studies, Breast Neoplasms, Radiotherapy, Adjuvant, Radiation Dosage, Organs at Risk, Coronary Vessels, Heart Disease Risk Factors
glioblastoma, Dose Escalation, PRIDE Trial, Bevacizumab, NTCP, FET PET, QA
Breast cancer, Brachytherapy, Liver metastases, Radiotherapy, Oligometastatic disease, Metastasis-directed therapy, MDT, HDR brachytherapy, Interventional radiotherapy